-
1 . Academic Journal
Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in Cameroon
- 저자
- by Calmy, A; Tovar Sanchez, T; Kouanfack, C; Mpoudi-Etame, M; Leroy, S, et al.
- 소스
- In The Lancet HIV October 2020 7(10):e677-e687